首页> 外国专利> USE OF A NEW ISOLATE OF NEOSPORA CANINUM FOR THE DEVELOPMENT OF DIAGNOSTIC TESTS AND FOR PREPARATION OF PRODUCTS FOR TREATMENT AND PREVENTION OF THE INFECTION CAUSED BY NEOSPORA

USE OF A NEW ISOLATE OF NEOSPORA CANINUM FOR THE DEVELOPMENT OF DIAGNOSTIC TESTS AND FOR PREPARATION OF PRODUCTS FOR TREATMENT AND PREVENTION OF THE INFECTION CAUSED BY NEOSPORA

机译:新犬新孢子虫的分离用于开发诊断试剂和制备用于治疗和预防新孢子虫感染的产品

摘要

The present invention relates to the use of a new isolate of Neospora caninum for the development of diagnostic tests and for the manufacture of products for the treatment and prevention of the infection caused by Neospora. The use of a new isolate of Neospora caninum (filed in the Culture Collection of Algae and Protozoa, with access number CCAP 2051/1), and the extracts obtained therefrom, in the preparation of diagnostic tests and in the manufacture of products for the treatment and prevention of the infection caused by Neospora, is based on the ease with which the new isolate converts from the tachyzoite to the bradyzoite stage under in vitro conditions. Additionally and with the same applications, the polypeptides and the polynucleotides obtained from the new isolate and the immunoreactive antibodies developed against Neospora antigens are used.
机译:本发明涉及新的犬新孢子虫分离株的用途,用于开发诊断测试和生产用于治疗和预防由犬新孢子虫引起的感染的产品。 >。使用新的犬新孢子虫分离株(在藻类和原生动物培养物保藏中心提交,保藏号为CCAP 2051/1)和从中获得的提取物的用途,用于诊断试验的制备和生产和治疗新孢子虫引起的感染的产品,是基于新分离物在体外条件下从速殖子阶段转变为缓殖子阶段的难易程度。此外,在相同的应用中,还使用了从新分离物中获得的多肽和多核苷酸以及针对 Neospora 抗原开发的免疫反应性抗体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号